Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve With reference to our intimation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has informed BSE that its Board Meeting, originally scheduled for 12th February 2026 to consider and approve the Un-audited Financial Results for the quarter ended 31st December 2025 (Q3 FY26), has been postponed to 14th February 2026. The delay is due to the unavailability of the statutory auditor, who could not provide the Limited Review Report in time. The company has apologized for the inconvenience.
This is a routine procedural update with a short 2-day delay in Q3 results announcement, likely to have minimal impact on the stock. However, the auditor's unavailability could raise minor governance concerns among investors if it recurs or delays results further.